Literature DB >> 20624205

The prognostic value of combined fractional flow reserve and TIMI frame count measurements in patients with stable angina pectoris and acute coronary syndrome.

Ali M Esen1, Goksel Acar, Ozlem Esen, Yunus Emiroglu, Mustafa Akcakoyun, Selcuk Pala, Hekim Karapinar, Ramazan Kargin, Irfan Barutcu, Muhsin Turkmen.   

Abstract

BACKGROUND: The aim of this study was to evaluate the prognostic value of different fractional flow reserve (FFR) cutoff values and corrected thrombolysis in myocardial infarction frame (TIMI) count (CTFC) measurements in a series of consecutive patients with moderate coronary lesions, including patients with unstable angina, myocardial infarction, and/or positive noninvasive functional test findings.
METHODS: We included 162 consecutive coronary patients in whom revascularization of a moderate coronary lesion was deferred based on a FFR value ≥0.75. Patients were divided according to the results of the intracoronary pressure and flow measurements into four groups: group A: 0.75 ≤ FFR ≤ 0.85 and CTFC > 28 (n=22), group B: 0.75 ≤ FFR ≤ 0.85 and CTFC ≤ 28 (n = 55), group C: 0.85 < FFR and CTFC > 28 (n = 19), and group D: 0.85 < FFR and CTFC ≤ 28 (n = 66). Adverse cardiac events and the presence of angina were evaluated at follow-up.
RESULTS: At a mean follow-up of 18 ± 10 months, cardiac event rate in patients with 0.75 ≤ FFR ≤ 0.85 and FFR > 0.85 were 22% and 9%, respectively (P = 0.026) and also, a trend was observed toward a higher cardiac event rate in case of an abnormal CTFC (CTFC > 28) compared to a normal CTFC (24% vs 12%, P = 0.066). Furthermore, a significantly higher cardiac event rate was observed when group A was compared to group D (31.8% vs 7.6%, respectively, P = 0.004).
CONCLUSION: Patients with potential microvascular dysfunction and borderline FFR values should be interpreted with caution, and management strategies should be guided not only by pressure measurement, but also by possibly supplementary clinical risk stratification and noninvasive tests. ©2010, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20624205     DOI: 10.1111/j.1540-8183.2010.00579.x

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  6 in total

1.  The relationship of coronary flow to neutrophil/lymphocyte ratio in patients undergoing primary percutaneous coronary intervention.

Authors:  Korhan Soylu; Serkan Yuksel; Okan Gulel; Ali Riza Erbay; Murat Meric; Halit Zengin; Muhtar Museyibov; Erdogan Yasar; Sabri Demircan
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

2.  Comprehensive assessment of coronary fractional flow reserve.

Authors:  Xiaolong Qi; Guoxin Fan; Deqiu Zhu; Wanrong Ma; Changqing Yang
Journal:  Arch Med Sci       Date:  2015-06-19       Impact factor: 3.318

3.  Long-term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions.

Authors:  Jerremy Weerts; Tobias Pustjens; Elsa Amin; Mustafa Ilhan; Leo F Veenstra; Ralph A L J Theunissen; Jindrich Vainer; Mera Stein; Lex A W Ruiters; Ben C G Gho; Arnoud W J Van't Hof; Saman Rasoul
Journal:  Catheter Cardiovasc Interv       Date:  2020-01-30       Impact factor: 2.692

4.  The Effects of Percutaneous Coronary Intervention on the Flow in Acute Coronary Syndrome Patients-Geometry in Focus.

Authors:  Agnes Orsolya Racz; Ildiko Racz; Gabor Tamas Szabo; Aron Uveges; Zsolt Koszegi; Bence Penczu; Rudolf Kolozsvari
Journal:  J Pers Med       Date:  2022-07-31

5.  Association of Lower Fractional Flow Reserve Values With Higher Risk of Adverse Cardiac Events for Lesions Deferred Revascularization Among Patients With Acute Coronary Syndrome.

Authors:  Shriti Masrani Mehta; Jeremiah P Depta; Eric Novak; Jayendrakumar S Patel; Yogesh Patel; David Raymer; Gabrielle Facey; Alan Zajarias; John M Lasala; Jasvindar Singh; Richard G Bach; Howard I Kurz
Journal:  J Am Heart Assoc       Date:  2015-08-19       Impact factor: 5.501

6.  Fractional Flow Reserve-Guided Strategy in Acute Coronary Syndrome. A Systematic Review and Meta-Analysis.

Authors:  José Luís Martins; Vera Afreixo; José Santos; Lino Gonçalves
Journal:  Arq Bras Cardiol       Date:  2018-09-21       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.